1. Bui, T.A*., Lestari, B.*, Nugroho, A.B.*, Nguyen, B., Stafford, N., Prehar, S., Zi, M., Potter, R. Triastuti, E., Baudoin, F.M., D’Souza, A., Wang, X., Cartwright, E.J, Oceandy, D. Nature Communications. 2025, 16, 1650
2. Naylor, J.M., Bùi, T.A., Frost, S., et al. Foundations for Developing a Hospital in the Home Pathway Following Low Trauma Hip Fracture: Using Data to Inform the Path. Home Health Care Management & Practice. 2025, 0, 0.
3. Wang, Y., Bui, T.A., Yang, X. et al. Advancements in gene therapies targeting mutant KRAS in cancers. Cancer Metastasis Rev. 2025; 44, 24
4. Bui, T.A.; Mei, H.; Sang, R.; Ortega, D.G.; Deng, W. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment. EBioMedicine 2024, 106, 105266.
5. Bui, T.A.; Yang, X.; Mei, H.; Aksoy, Y.A.; Deng,F.; Hutvagner, G.; Deng., W. Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment. Advanced Functional Materials 2024, 2402630.
6. Mehta, M.; Bui, T.A.;Care, A.; Deng, W. Targeted polymer lipid hybrid nanoparticles for in-vitro siRNA therapy in triple-negative breast cancer. Journal of Drug Delivery Science and Technology 2024, 98, 105911
7. Bui, T. A.; Stafford, N.; Oceandy, D., Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cells 2023, 12, 7.
8. Mehta, M.; Bui, T.A.;Yang, X.; Aksoy, Y.; Goldys, E. M.; Deng, W., Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development. ACS Materials Au 2023.
9. Nugroho, A. B.; Stafford, N.;Zi, M.; Prehar,S.; Potter, R.;Kwon,D.; Kohar, Y. S.; Triastuti, E.; Bui,T. A.;Cartwright, E. J.; Oceandy, D., Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice. JACC Basic Transl Sci 2022, 7 (9), 859-875.
10. Pawitan, J. A.; Bui, T. A.;Mubarok, W.; Antarianto, R. D.; Nurhayati, R. W.; Dilogo, I. H.; Oceandy, D., Enhancement of the Therapeutic Capacity of Mesenchymal Stem Cells by Genetic Modification: A Systematic Review. Front Cell Dev Biol 2020,8, 587776.
11. Nguyen, B. Y.; Ruiz-Velasco, A.; Bui, T.;Collins, L.; Wang, X.; Liu, W., Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials. Br J Pharmacol 2019,176 (22), 4302-4318.
12. Triastuti, E.; Nugroho, A. B.; Zi, M.;Prehar, S.; Kohar, Y. S.; Bui, T.A.;Stafford, N.; Cartwright, E. J.; Abraham, S.; Oceandy, D., Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. Br J Pharmacol 2019, 176 (20), 3956-3971.
13. Zi, M.;Stafford, N.; Prehar, S.; Baudoin, F.;Oceandy, D.; Wang, X.; Bui, T.;Shaheen, M.; Neyses, L.; Cartwright, E. J., Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains. Curr Res Physiol 2019,1, 1-10.
14. Robertson, A.; Mohamed, T. M.; El Maadawi, Z.; Stafford, N.; Bui, T.; Lim, D. S.; Cartwright, E. J.; Oceandy, D., Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival. Stem Cell Res 2017,20, 42-49